Anthony Hooper - Amgen Insider |
| AMGN -- Mexico Stock | MXN 3,659 63.42 1.70% |
Executive VP of Global Commercial Operations
Mr. Anthony C. Hooper is the Executive Vice President Global Commercial Operations of Amgen Inc. From March 2010 to October 2011, Mr. Hooper was Senior Vice President, Commercial Operations and President, U.S., Japan and Intercontinental of BMS. From January 2009 to March 2010, Mr. Hooper was President, Americas of BMS. From January 2004 to January 2009, He was President, U.S. Pharmaceuticals, Worldwide Pharmaceuticals Group, a division of BMS. Prior to this, Mr. Hooper held various senior leadership positions at BMS. Prior to joining BMS, Mr. Hooper was Assistant Vice President of Global Marketing for Wyeth Laboratories.
Age: 62 EVP Since 2011
805-447-1000 http://www.amgen.com
Anthony Hooper Latest Insider Activity
|
Management Efficiency
The company has return on total asset (ROA) of 8.84 % which means that it generated profit of $8.84 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.59 % meaning that it generated $9.59 on every $100 dollars invested by stockholders.The company has accumulated 35.54 B in total debt with debt to equity ratio (D/E) of 227.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen has Current Ratio of 3.8 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Entity Summary
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in Mexico and traded on Mexico Stock Exchange. It employs 20800 people.Amgen (AMGN) is traded on Mexico Stock Exchange in Mexico. It is located in One Amgen Center Drive and employs 20,800 people.Amgen Leadership Team
| Frank Herringer, Director | |
| Francois Carbonnel, Director | |
| Rebecca Henderson, Director, Ph.D | |
| Annette Such, Executive | |
| Sanders Williams, Director | |
| Vance Coffman, Director, Ph.D | |
| Tyler Jacks, Director, Ph.D | |
| Brian McNamee, President | |
| Gregory Garland, Director | |
| Charles Holley, Director | |
| Esteban Santos, President | |
| Jonathan Graham, President | |
| Sean Harper, President, Ph.D | |
| Ellen Kullman, Director | |
| Frank Biondi, Director | |
| Arvind Sood, Executive | |
| David Meline, CFO | |
| Ronald Sugar, Director, Ph.D | |
| Stuart Tross, President | |
| Robert Bradway, Chairman | |
| Wanda Austin, Director | |
| Robert Eckert, Director | |
| Madhavan Balachandran, EVP | |
| Lori Johnston, President | |
| Brian Druker, Director, Ph.D | |
| Cynthia Patton, President | |
| Greg Garland, Director | |
| Judith Pelham, Director | |
| David Baltimore, Director, Ph.D | |
| Fred Hassan, Director | |
| David Piacquad, President | |
| Anthony Hooper, EVP |
Stock Performance Indicators
| Shares Outstanding | 730.7 M |
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Global Markets Map |
Pair Correlation
Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Amgen and Banco de Chile. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
| Run Pair Correlation |
Check also Trending Equities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.